Results 261 to 270 of about 27,333,880 (308)

Atypical Forms of M. tuberculosis

Diseases of the Chest, 1961
SUMMARY Atypical forms of M. tuberculosis have been discussed from the earliest identification of variations to the present time, and instead of being a mystery, it is all within the laws of biology. While there may be phenomena not yet clearly understood in the life of bacteria, the mutation theory of DeVries seems to be adequate to explain most of
openaire   +1 more source

?????????????????????? ???????????????? ???????????????????????? ?????? ?????????????????????? ?????????????? M. tuberculosis ???????????? Beijing

2013
?????????????????? ???????????????????? ???????????????? ???????????????????????? ?? ???????????? ???? ?????????????????? ??????????????????????, ?????????????????????? ???????????????????? M. tuberculosis ???????????? Beijing ?? ???????????????????? ?????????? ???????????????????? ??????????. ?????????????? ?????????????? ???????????? ?????????????????
openaire   +1 more source

M. TUBERCULOSIS STUDY

American Journal of Nursing, 1998
Tracy B. Agerton, Betty Gore, Carol Pozsik   +2 more
openaire   +1 more source

Clinical presentation and outcome of tuberculosis patients infected by M. africanum versus M. tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2007
A tuberculosis (TB) case contact study in the Gambia.To test whether Mycobacterium africanum, which has lost around 68 kb compared with M. tuberculosis sensu stricto, causes less severe TB disease.We genotyped mycobacterial isolates and compared clinical and radiological characteristics as well as outcome data of M.
B C, de Jong, P C, Hill, A, Aiken, D J, Jeffries, A, Onipede, P M, Small, R A, Adegbola, T P, Corrah   +7 more
openaire   +1 more source

DNA gyrase inhibitor targets M. tuberculosis

Nature Reviews Drug Discovery, 2022
openaire   +2 more sources

[Novel vaccines against M. tuberculosis].

Kekkaku : [Tuberculosis], 2007
CDC and ACET in U.S.A. reported that novel vaccines instead of BCG are required for the protection against infection of Mycobacterium tuberculosis worldwide. However, no novel vaccine for clinical use has not yet been developed in the world including U.S.A. and Europe.
openaire   +1 more source

Inhibition of innate immune cytosolic surveillance by an M. tuberculosis phosphodiesterase.

Nature Chemical Biology, 2017
Ruchi Jain Dey, Bappaditya Dey, Yue Zheng, Laurene S. Cheung, Jie Zhou, David A. Sayre, Pankaj Kumar, Haidan Guo, G. Lamichhane, H. Sintim, W. Bishai   +10 more
semanticscholar   +1 more source

Chewing the fat: lipid metabolism and homeostasis during M. tuberculosis infection.

Current Opinion in Microbiology, 2016
Rustin R. Lovewell, C. Sassetti, B. VanderVen   +2 more
semanticscholar   +1 more source

Isolation of M. tuberculosis RNA from Sputum

2003
Analysis of RNA has many applications and has become increasingly important both in basic research and clinical application. The type and number of particular mRNA transcripts expressed in M. tuberculosis (MTB) bacilli under various conditions can provide insight into models of pathogenesis.
openaire   +2 more sources

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials.

Vaccine, 2013
A. Arbués, J. I. Aguiló, J. Gonzalo-Asensio, D. Marinova, S. Uranga, E. Puentes, Conchita Fernandez, A. Parra, P. Cardona, C. Vilaplana, V. Ausina, Ann Williams, S. Clark, Wladimir Malaga, C. Guilhot, B. Gicquel, Carlos Martín   +16 more
semanticscholar   +1 more source